Prevalence of Pediatric Eating Disorders in Children with Inherited Metabolic Diseases
Study of the Prevalence of Pediatric Eating Disorders in Inherited Metabolic Diseases With Dietary Treatment
This study is trying to find out how common eating disorders are in young children with inherited metabolic diseases who are on special diets.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 12 Months to 6 Years |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT06471842 on ClinicalTrials.gov |
What this trial studies
This observational study aims to estimate the prevalence of Pediatric Eating Disorders (PED) in children aged 12 months to 6 years 11 months who have Inherited Metabolic Diseases (IMD) and are undergoing dietary treatment. The study will utilize validated questionnaires, including the Montreal Children's Hospital feeding scale, to gather data on feeding difficulties and their impact on psychomotor and emotional development. By identifying the prevalence of PED in this population, the study seeks to enhance awareness and improve care for affected children. It will be conducted at the Necker-Enfants Malades hospital in Paris.
Who should consider this trial
Good fit: Ideal candidates are children aged 12 months to 6 years 11 months diagnosed with an inherited metabolic disease who have undergone dietary diversification.
Not a fit: Patients with associated chronic diseases, diagnosed Autism Spectrum Disorder, or those with multiple disabilities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recognition and management of eating disorders in children with inherited metabolic diseases.
How similar studies have performed: While there is limited data on the prevalence of PED in IMDs, similar studies in other pediatric populations have shown the importance of addressing feeding disorders, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient from 12 months to 6 years and 11 months old * Patient with an Inherited Metabolic Diseases with dietary treatment * Patient having experimented a dietary diversification at least 6 month prior * Patient whose parents do not object to their participation in the study Exclusion Criteria: * Patient with an associated chronic disease * Patient with diagnosed Autistic Spectrum Disorder (ASD) or Pervasive Developmental Disorders (PDD) * Patient born before 36 weeks of amenorrhea * Patient with multiple disabilities * Patient with dystonia * Patient with absent or unstable head posture * Patient whose parents do not fully understand or speak French
Where this trial is running
Paris
- Necker Enfants Malades Hospital — Paris, France (Recruiting)
Study contacts
- Principal investigator: Manon Tessier — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Manon Tessier
- Email: manon.tessier@aphp.fr
- Phone: +33 1 87 89 20 65
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.